Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
about
Neuroinflammation in Parkinson's disease and its potential as therapeutic targetInflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 ProteinInterleukin-1beta-induced reduction of tissue water diffusion in the juvenile rat brain on ADC MRI is not associated with (31)P MRS-detectable energy failure.Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigraPentoxifylline Neuroprotective Effects Are Possibly Related to Its Anti-Inflammatory and TNF-Alpha Inhibitory Properties, in the 6-OHDA Model of Parkinson's Disease.Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study.Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson's Disease.The neuroimmune-neuroplasticity interface and brain pathology.Synthesis of 1,4-anthracene-9,10-dione derivatives and their regulation of nitric oxide, IL-1β and TNF-α in activated RAW264.7 cells.Beneficial effects of liraglutide (GLP1 analog) in the hippocampal inflammation.Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide.A New Venue of TNF Targeting.Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
P2860
Q26783305-C4DE6F65-8522-44AD-8DE9-E9BE72767D85Q28553088-04565A8E-0ABA-48A5-BC12-A5FD4EB86308Q31060275-5127EBCA-A657-4E3A-9B78-2C96F4ACBD17Q34768987-4180F340-6544-460A-8F3B-D47BCB671DB1Q36154563-57647EEE-CC92-41AB-85AC-6671101F8197Q39055955-A17922D1-3E2D-45C8-BEDB-814E2B462741Q39965616-6CA0E014-772E-4D72-86E2-CF1957699337Q42152168-164EB2AB-4CAA-4FD5-8764-D7EA2461C539Q43055038-1A3EA0E4-6FAA-4265-BD00-27F215E30092Q44065021-B4B976F5-63DC-4E4D-8F7D-A36E42E6B810Q48209483-FC230795-8150-4916-B6C6-268576FA4D98Q54981317-7508D8EC-CCC7-498E-9FB2-9B5581746769Q55001725-CD434DF4-9804-468C-8306-12B77D8410FAQ55517799-D19E0CE6-FE42-4AA9-9E55-E6079A313A37
P2860
Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interleukin-1β and tumor necro ...... rapies in Parkinson's Disease?
@en
type
label
Interleukin-1β and tumor necro ...... rapies in Parkinson's Disease?
@en
prefLabel
Interleukin-1β and tumor necro ...... rapies in Parkinson's Disease?
@en
P2093
P2860
P356
P1476
Interleukin-1β and tumor necro ...... rapies in Parkinson's Disease?
@en
P2093
Juan C Casabona
Mariana Puntel
María C Leal
P2860
P356
10.3389/FNCEL.2013.00053
P577
2013-04-29T00:00:00Z